Intraarticular Injections of the Hip and Knee With Triamcinolone Versus Ketorolac: A Randomized Controlled Trial
- Conditions
- Arthritis KneeArthritis of Hip
- Interventions
- Registration Number
- NCT04441112
- Lead Sponsor
- Saint Alphonsus Regional Medical Center
- Brief Summary
Clinicians commonly utilize intraarticular injections to treat symptomatic primary arthritis. Steroid injections are common yet have immune-modulating effects and can alter gene expression which may delay definitive arthroplasty and further damage cartilage. Non-steroidal anti-inflammatory (NSAID) injections may offer a safer profile due to their differing mechanism of action; however, there is a relative dearth of information regarding their efficacy. This non-inferiority study compares the effectiveness of triamcinolone versus ketorolac in treating symptoms of moderate to advanced primary osteoarthritis of the hip and knee.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 120
- Symptomatic, radiographically proven degenerative joint disease in the hip or knee
- recent injection in the hip or knee within the previous 3 months
- history of traumatic osteoarthritis or ligamentous reconstruction
- chronic narcotic use
- history of inflammatory or neuropathic arthropathy
- pregnant and/or nursing women
- allergy or strong reaction to study medications
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Ketorolac Intraarticular Hip Injection Ketorolac Intraarticular Injection Patients will receive an intraarticular hip injection with ketorolac. Triamcinolone Intraarticular Hip Injection Triamcinolone Intraarticular Injection Patients will receive an intraarticular hip injection with triamcinolone. Ketorolac Intraarticular Knee Injection Ketorolac Intraarticular Injection Patients will receive an intraarticular knee injection with ketorolac. Triamcinolone Intraarticular Knee Injection Triamcinolone Intraarticular Injection Patients will receive an intraarticular knee injection with triamcinolone.
- Primary Outcome Measures
Name Time Method Change in Visual Analogue Scale (Baseline to One Week Post-injection) Comparing baseline to one week post-injection Pain Score
Change in PROMIS Global Health Scores (Baseline to One Month Post-injection) Comparing baseline to one month post-injection Overall patient wellbeing
Change in Visual Analogue Scale (Baseline to One Month Post-injection) Comparing baseline to one month post-injection Pain Score
Change in Visual Analogue Scale (Baseline to Three Months Post-injection) Comparing baseline to three months post-injection Pain Score
Change in PROMIS Global Health Scores (Baseline to One Week Post-injection) Comparing baseline to one week post-injection Overall patient wellbeing
Change in PROMIS Global Health Scores (Baseline to Three Months Post-injection) Comparing baseline to three months post-injection Overall patient wellbeing
Change in Knee Injury and Osteoarthritis Outcome Score Jr. (Baseline to One Week Post-injection) Comparing baseline to one week post-injection Functionality and pain of affected knee
Change in Knee Injury and Osteoarthritis Outcome Score Jr. (Baseline to One Month Post-injection) Comparing baseline to one month post-injection Functionality and pain of affected knee
Change in Knee Injury and Osteoarthritis Outcome Score Jr. (Baseline to Three Months Post-injection) Comparing baseline to three months post-injection Functionality and pain of affected knee
Change in Hip Injury and Osteoarthritis Outcome Score Jr. (Baseline to One Week Post-injection) Comparing baseline to one week post-injection Functionality and pain of affected hip
Change in Hip Injury and Osteoarthritis Outcome Score Jr. (Baseline to One Month Post-injection) Comparing baseline to one month post-injection Functionality and pain of affected hip
Change in Hip Injury and Osteoarthritis Outcome Score Jr. (Baseline to Three Months Post-injection) Comparing baseline to three months post-injection Functionality and pain of affected hip
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Saint Alphonsus Regional Medical Center
🇺🇸Boise, Idaho, United States